Uwe Pieles

Prof. Dr. Uwe Pieles

University of Applied Sciences, School of Life Sciences, Gründenstrasse 40, CH 4132, Muttenz, Switzerland

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2006 in Sensors
Verified
Journal Article
Open access
PDF file
PSPatrick Shahgaldian
Patrick Shahgaldian
UPUwe Pieles
Uwe Pieles
In view of the chiral nature of many bio-molecules (and all bio-macromolecules),most of therapeutically active compounds which target these molecules need to be chiraland “good handed” to be effective. In addition to asymmetric synthetic and separationmethodologies, enantioselective chemical sensors, able to distinguish between twoenantiomers of the same molecule, are of relevance. In order to design these sensing tools,two major classes of enantioselective layers have been developed. The first is based onmolecularly imprinted polymers which are produced (polymerized) in the presence of theirtarget, thus the polymeric material keep in “memory” the size and the shape of this moleculeand the system could be used for sensing (not reviewed here). The second approach makesuse of sensitive layers containing chiral macrocyclic receptors able of stereoselectivemolecular recognition; these receptors are mainly based on cyclodextrins. In thiscontribution, are reviewed achievements in the use of native or chemically modifiedcyclodextrins for chiral sensing purposes (at interfaces). Potentialities of other chiralmacrocycles based on calixarenes, calix-resorcinarenes or crown-ethers as supramolecularreceptors for enantioselective sensing are discussed.

1 January 2011 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
EGEmina Besic Gyenge
Emina Besic Gyenge
XDXenia Darphin
Xenia Darphin
AWAmina Wirth
Amina Wirth
UPUwe Pieles
Uwe Pieles
HWHeinrich Walt
Heinrich Walt
CMCaroline Maake
Caroline Maake
Head and neck squamous cell carcinoma (HNSCC) is currently the eighth leading cause of cancer death worldwide. The often severe side effects, functional impairments and unfavorable cosmetic outcome of conventional therapies for HNSCC have prompted the quest for novel treatment strategies, including the evaluation of nanotechnology to improve e.g. drug delivery and cancer imaging. Although silica nanoparticles hold great promise for biomedical applications, they have not yet been investigated in the context of HNSCC. In the present in-vitro study we thus analyzed the cytotoxicity, uptake and intracellular fate of 200-300 nm core-shell silica nanoparticles encapsulating fluorescent dye tris(bipyridine)ruthenium(II) dichloride with hydroxyl-, aminopropyl- or PEGylated surface modifications (Ru@SiO2-OH, Ru@SiO2-NH2, Ru@SiO2-PEG) in the human HNSCC cell line UMB-SCC 745.

1 May 2010 in Chimia
Verified
Journal Article
Open access
MWMarcus Waser
Marcus Waser
CSChristian Siebenhaar
Christian Siebenhaar
JZJennifer Zampese
Jennifer Zampese
GGGerhard Grundler
Gerhard Grundler
Edwin Charles ConstableEdwin Charles Constable
Edwin Charles Constable
UPUwe Pieles
Uwe Pieles